In this case, the tissue tested negative for several biomarkers of GBM classification, including neurofibromatosis (NF1), TP53, platelet-derived growth factor receptor alpha polypeptide (PDGFRA), and neurofilament light chain (NEFL), indicating a classical subtype of GBM favored. This evidence concerns the gene PDGFRA and glioblastoma.